Literature DB >> 24742750

Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.

Yumiko Nozaki1, Yayoi Honda2, Shinji Tsujimoto3, Hitoshi Watanabe4, Takeshi Kunimatsu5, Hitoshi Funabashi6.   

Abstract

Field potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in an electrocardiogram, is reported to be a useful tool to predict K(+) channel and Ca(2+) channel blocker effects on QT interval. However, there is no report showing that this technique can be used to predict multichannel blocker potential for QT prolongation. The aim of this study is to show that FPD from MEA (Multielectrode array) of hiPS-CMs can detect QT prolongation induced by multichannel blockers. hiPS-CMs were seeded onto MEA and FPD was measured for 2min every 10min for 30min after drug exposure for the vehicle and each drug concentration. IKr and IKs blockers concentration-dependently prolonged corrected FPD (FPDc), whereas Ca(2+) channel blockers concentration-dependently shortened FPDc. Also, the multichannel blockers Amiodarone, Paroxetine, Terfenadine and Citalopram prolonged FPDc in a concentration dependent manner. Finally, the IKr blockers, Terfenadine and Citalopram, which are reported to cause Torsade de Pointes (TdP) in clinical practice, produced early afterdepolarization (EAD). hiPS-CMs using MEA system and FPDc can predict the effects of drug candidates on QT interval. This study also shows that this assay can help detect EAD for drugs with TdP potential.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early afterdepolarization (EAD); Field potential duration (FPD); Human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs); Multielectrode array (MEA); QT prolongation; Torsade de Pointes (TdP)

Mesh:

Substances:

Year:  2014        PMID: 24742750     DOI: 10.1016/j.taap.2014.04.007

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  14 in total

1.  Action Potential Shape Is a Crucial Measure of Cell Type of Stem Cell-Derived Cardiocytes.

Authors:  Glenna C L Bett; Aaron D Kaplan; Randall L Rasmusson
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

Review 2.  Dominant rule of community effect in synchronized beating behavior of cardiomyocyte networks.

Authors:  Kenji Yasuda
Journal:  Biophys Rev       Date:  2020-05-04

Review 3.  Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients.

Authors:  Mark McCauley; Sharath Vallabhajosyula; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2016-03-22

4.  Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells.

Authors:  Francesca Stillitano; Jens Hansen; Chi-Wing Kong; Ioannis Karakikes; Christian Funck-Brentano; Lin Geng; Stuart Scott; Stephan Reynier; Ma Wu; Yannick Valogne; Carole Desseaux; Joe-Elie Salem; Dorota Jeziorowska; Noël Zahr; Ronald Li; Ravi Iyengar; Roger J Hajjar; Jean-Sébastien Hulot
Journal:  Elife       Date:  2017-01-30       Impact factor: 8.140

Review 5.  Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?

Authors:  Luca Sala; Milena Bellin; Christine L Mummery
Journal:  Br J Pharmacol       Date:  2016-09-20       Impact factor: 8.739

6.  Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3',5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Bin Lin; Xianming Lin; Maxine Stachel; Elisha Wang; Yumei Luo; Joshua Lader; Xiaofang Sun; Mario Delmar; Lei Bu
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-09       Impact factor: 5.555

7.  On-chip spatiotemporal electrophysiological analysis of human stem cell derived cardiomyocytes enables quantitative assessment of proarrhythmia in drug development.

Authors:  Yumiko Asahi; Tomoyo Hamada; Akihiro Hattori; Kenji Matsuura; Masao Odaka; Fumimasa Nomura; Tomoyuki Kaneko; Yasuyuki Abe; Kiyoshi Takasuna; Atsushi Sanbuissho; Kenji Yasuda
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

8.  Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation.

Authors:  Susanne Rehnelt; Daniela Malan; Krisztina Juhasz; Benjamin Wolters; Leo Doerr; Matthias Beckler; Ralf Kettenhofen; Heribert Bohlen; Tobias Bruegmann; Philipp Sasse
Journal:  Int J Mol Sci       Date:  2017-12-06       Impact factor: 5.923

9.  Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes.

Authors:  Hendrik Lapp; Tobias Bruegmann; Daniela Malan; Stephanie Friedrichs; Carsten Kilgus; Alexandra Heidsieck; Philipp Sasse
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

10.  Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.

Authors:  Chris Denning; Viola Borgdorff; James Crutchley; Karl S A Firth; Vinoj George; Spandan Kalra; Alexander Kondrashov; Minh Duc Hoang; Diogo Mosqueira; Asha Patel; Ljupcho Prodanov; Divya Rajamohan; William C Skarnes; James G W Smith; Lorraine E Young
Journal:  Biochim Biophys Acta       Date:  2015-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.